Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT00870987

Completed

Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malaria (DNA-Ad)

Malaria
NCT02388165

Terminated

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation (STRIVE)

Staphylococcal Vaccine
NCT03614975

Completed

Immunologic Response to Influenza Vaccination in Children and Adolescents

Immune Response | Influenza, Human
NCT01024686

Terminated

Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine

Malaria
NCT01106092

Completed

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis | Poliomyelitis Vaccines
NCT01945268

Completed

Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (IVVE:Pilot)

Heart Failure
NCT01030822

Completed

Booster and Catch-up Vaccination With Vaccine GSK1024850A

Infections, Streptococcal
NCT02035696

Completed

Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

Influenza
NCT03137927

Completed

A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Whooping Cough
NCT00560066

Completed

Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Seasonal Influenza | Vaccine
NCT00133575

Completed

ACAM 3000 MVA at Harvard Medical School

Smallpox
NCT02164110

Completed

To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children

Prevention Harmful Effects
NCT01386164

Completed

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults (HIPAVAC)

HIV | Human Papillomavirus
NCT00452452

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

Pneumococcal Infections
NCT01113281

Completed

Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

Tuberculosis
NCT00500357

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

Vaccines, Pneumococcal Conjugate Vaccine
NCT00125008

Completed

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Typhoid | Paratyphoid Fever
NCT00656409

Completed

Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)

Ataxia Telangiectasia (AT)
NCT00232947

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza
NCT00813761

Completed

Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems

Myopia
NCT06113744

Recruiting

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

SARS-CoV-2 Infection
NCT04484532

Completed

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Acute Myeloid Leukemia | Myelodysplastic Syndrome
NCT01239875

Completed

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Cutaneous B-cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Adult Grade III Lymphomatoid Granulomatosis | Adult Lymphoblastic Lymphoma | Grade 1 Follicular Lymphoma
NCT01148459

Completed

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children

Malaria
NCT06056050

Active, not recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria
NCT05166876

Terminated

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19 (CCBCRISIS04)

COVID-19
NCT05569746

Completed

A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Hemolytic-Uremic Syndrome | Pediatric Kidney Disease | Diarrhea-Associated Hemolytic Uremic Syndrome
NCT03169751

Unknown

An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures

Epilepsy | Non-Epileptic Seizure | Motor Seizure
NCT03620838

Unknown

Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial) (ERROR2)

Endometrioma | Ovarian Reserve
NCT01560442

Unknown

Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine (PUPIDOL)

Opiate Dependent | Previous Illicit Drug Use
NCT00004199

Completed

Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer

Lung Cancer
NCT06202703

Recruiting

Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity (SEA)

Vaccine-Preventable Diseases
NCT02111941

Completed

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma
NCT06019559

Completed

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

Obesity
NCT02274415

Completed

Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease (DREVAC)

Sickle Cells Disease | Invasive Pneumococcal Infections
NCT03674177

Completed

A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

Respiratory Syncytial Virus Infections
NCT00841763

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease
NCT04298606

Completed

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Pneumonia | Chronic Obstructive Pulmonary Disease | Lung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IB Lung Cancer AJCC v8
NCT00956111

Completed

A Clinical Trial With Influenza A/H1N1 Vaccines

Influenza
NCT00463437

Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Streptococcus Pneumoniae Vaccines
NCT07585383

Not yet recruiting

A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects

Schizophrenia
NCT07252804

Recruiting

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases (MENB-PARD)

Autoimmune Rheumatologic Disease
NCT07081984

Recruiting

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Cervical Cancer | HNSCC | HPV 16+ Recurrent or Metastatic Cancer
NCT06195384

Recruiting

Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

Solid Tumor, Adult
NCT06132438

Not yet recruiting

Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

Glioblastoma
NCT06095934

Recruiting

Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment

NSCLC | EGFR Gene Mutation
NCT05471635

Recruiting

Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination) (WORLDCOV)

COVID-19 Vaccines
NCT05108818

Recruiting

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Influenza, Human
NCT05059821

Recruiting

Personalized Cancer Vaccine in Egyptian Cancer Patients (PROVE)

Hepatocellular Carcinoma
NCT05017792

Recruiting

Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt

Covid19

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations